Back to Search
Start Over
Intra- and Extracellular Activities of Dicloxacillin against Staphylococcus aureus In Vivo and In Vitro
- Source :
- Antimicrobial Agents and Chemotherapy. 54:2391-2400
- Publication Year :
- 2010
- Publisher :
- American Society for Microbiology, 2010.
-
Abstract
- Antibiotic treatment of Staphylococcus aureus infections is often problematic due to the slow response and recurrences. The intracellular persistence of the staphylococci offers a plausible explanation for the treatment difficulties because of the impaired intracellular efficacies of the antibiotics. The intra- and extracellular time- and concentration-kill relationships were examined in vitro with THP-1 cells and in vivo by use of a mouse peritonitis model. The in vivo model was further used to estimate the most predictive pharmacokinetic/pharmacodynamic (PK/PD) indices (the ratio of the maximum concentration of drug in plasma/MIC, the ratio of the area under the concentration-time curve/MIC, or the cumulative percentage of a 24-h period that the free [ f ] drug concentration exceeded the MIC under steady-state pharmacokinetic conditions [ fT MIC ]) for dicloxacillin (DCX) intra- and extracellularly. In general, DCX was found to have similar intracellular activities, regardless of the model used. Both models showed (i) the relative maximal efficacy (1-log-unit reduction in the numbers of CFU) of DCX intracellularly and (ii) the equal relative potency of DCX intra- and extracellularly, with the MIC being a good indicator of the overall response in both situations. Discordant results, based on data obtained different times after dosing, were obtained from the two models when the extracellular activity of DCX was measured, in which the in vitro model showed a considerable reduction in the number of CFU from that in the original inoculum (3-log-unit decrease in the number of CFU after 24 h), whereas the extracellular CFU reduction achieved in vivo after 4 h did not exceed 1 log unit. Multiple dosing of DCX in vivo revealed increased extra- and intracellular efficacies (2.5 log and 2 log units of reduction in the numbers of CFU after 24 h, respectively), confirming that DCX is a highly active antistaphylococcal antibiotic. PK/PD analysis revealed that fT MIC is the index that is the most predictive of the outcome of infection both intra- and extracellularly.
- Subjects :
- Staphylococcus aureus
Doublecortin Protein
medicine.drug_class
Antibiotics
Colony Count, Microbial
Intracellular Space
Microbial Sensitivity Tests
In Vitro Techniques
Peritonitis
Pharmacology
Biology
medicine.disease_cause
Dicloxacillin
Cell Line
Mice
Pharmacokinetics
In vivo
Extracellular
medicine
Animals
Humans
Experimental Therapeutics
Pharmacology (medical)
Macrophages
Staphylococcal Infections
Anti-Bacterial Agents
Infectious Diseases
Pharmacodynamics
Female
Extracellular Space
Intracellular
medicine.drug
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 54
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi.dedup.....b9ad613b9b4b890181f7fd01fd2e2f65
- Full Text :
- https://doi.org/10.1128/aac.01400-09